Androgen upregulates the palmitoylation of eIF3L in human prostate LNCaP cells

Background: Prostate cancer is the second leading cause of cancer-related deaths in Western countries. Most patients diagnosed with advanced prostate cancer can be treated with the main treatment: androgen deprivation therapy (ADT). The androgen receptor (AR) signaling axis plays a pivotal role in t...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Onco Targets Ther
Hlavní autoři: Cui, Luwei, Liu, Ming, Lai, Shicong, Hou, Huimin, Diao, Tongxiang, Zhang, Dalei, Wang, Miao, Zhang, Yaoguang, Wang, Jianye
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove 2019
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6556480/
https://ncbi.nlm.nih.gov/pubmed/31239713
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S193480
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky